+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629C-->A polymorphism and a novel promoter variant are independently associated with CETP concentration



Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629C-->A polymorphism and a novel promoter variant are independently associated with CETP concentration



Human Molecular Genetics 12(2): 111-123



The TaqIB polymorphism in intron 1 of the cholesteryl ester transfer protein (CETP) gene is associated with plasma CETP concentration, high-density lipoprotein cholesterol (HDL-C) and coronary artery disease (CAD). These associations are generally thought to arise from linkage disequilibrium between TaqIB and (an)other functional polymorphism(s). To identify putative functional sites, we investigated phenotypic associations of TaqIB and four tightly linked polymorphisms (novel -2708G-->A and +784CCC-->A, and previously identified -971G-->A and -629C-->A) in 709 males with CAD (REGRESS). In addition to genotype analyses, a novel method to estimate haplotype effects was used to examine the individual and joint effects of these DNA variants on CETP concentration and HDL-C. All polymorphisms were associated with CETP concentration and HDL-C, except for -971 with HDL-C. Stepwise regression and haplotype analyses indicated that only -629 was independently associated with HDL-C. Similar analyses additionally indicated that -2708 and -629 were independently associated with CETP concentration, whereby the most frequent alleles acted in a cumulative manner. Nonetheless, detailed haplotype analysis revealed that a 3-polymorphism haplotype model consisting of -2708, -629 and -971 explained the variation in CETP concentration best. The involvement of -971 could be due to interaction effects that were observed between -971 and both -629 (P<0.001) and -2708 (P=0.047). In conclusion, the TaqIB polymorphism is not instrumental in determining CETP or HDL-C levels, but is a marker for the -629 promoter variant. Our analyses, furthermore, indicate that the -2708 and -971 polymorphisms are likely to play a role in determining CETP concentration.

(PDF emailed within 1 workday: $29.90)

Accession: 046211975

Download citation: RISBibTeXText

PMID: 12499392


Related references

Haplotype analysis of the Cetp gene: not TaqIb, but the closely linked -629C->A polymorphism and a novel promoter variant are independently associated with Cetp concentration. Human Molecular Genetics 12(2): 111-123, 2003

Haplotype analysis of the CETP gene: Not TaqIB, but the closely linked -629CfwdarwA polymorphism and a novel promoter variant are independently associated with CETP concentration. Human Molecular Genetics 12(2): 111-123, 15 January, 2003

Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study. Human Molecular Genetics 14(18): 2607-2618, 2005

The -629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men. Atherosclerosis 159(1): 187-192, 2001

New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation. Arteriosclerosis, Thrombosis, and Vascular Biology 20(2): 507-515, 2000

The association of HDL cholesterol concentration with the -629C>A CETP promoter polymorphism is not fully explained by its relationship with plasma cholesteryl ester transfer. Scandinavian Journal of Clinical and Laboratory Investigation 68(2): 99-105, 2007

The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy. Journal of the American College of Cardiology 43(5): 854-857, 2004

Haplotype analysis of CETP gene polymorphisms in relation with coronary artery disease, HDL-cholesterol and CETP activity in the AtheroGene Study. European Heart Journal 23(Abstract Suppl.): 373, August-September, 2002

Fluorescence-based detection of the CETP TaqIB polymorphism: false positives with the TaqMan-based exonuclease assay attributable to a previously unknown gene variant. Clinical Chemistry 47(5): 852-857, 2001

The -628 C/A polymorphism in the CETP promoter modulates plasma CETP mass and HDL cholesterol. Circulation 98(17 SUPPL ): I739, Oct 27, 1998

Influence of CETP gene -629C/A polymorphism on the efficacy of atorvastatin treatment and clinical outcome. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 30(5): 553-558, 2014

CETP gene TaqIB polymorphism and plasma lipids in patients with overweight and obesity. Roczniki Panstwowego Zakladu Higieny 63(2): 149-154, 2012

Association of Cholesteryl Ester Transfer Protein (CETP) Gene -629C/A Polymorphism with Angiographically Proven Atherosclerosis. Indian Journal of Clinical Biochemistry 32(2): 235-238, 2017

CETP deficiency due to a novel mutation in the CETP gene promoter and its effect on cholesterol efflux and selective uptake into hepatocytes. Atherosclerosis 216(2): 370-373, 2011

TaqIB polymorphism in the CETP gene modulates the impact of HC/LF diet on the HDL profile in healthy Chinese young adults. Journal of Nutritional Biochemistry 21(11): 1114-1119, 2011